CLEVELAND--(BUSINESS WIRE)--Cleveland HeartLab LLC (CHL) today announced that it will host the first of what will be an annual symposium on cardiovascular disease. The symposium, which this year is entitled “Where Inflammation Meets Lipids,” has attracted more than a dozen thought-leading authorities who will speak on a wide range of cardiovascular disease prevention, diagnosis and management topics.
